What This Report Will Provide?

This study involved four major activities in estimating the current size of the oligonucleotide synthesis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Expected Revenue Growth:

[246 Pages Report] The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6%

Major Growth Boosters:

This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques, increasing government funding, and the growing focus on personalized medicine.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350

Recent Developments:

In 2020, Danaher Corporation (US) opened IDT China, an official business entity, to better serve its customer base in the region, reach out to new customers, and provide easier access to its complete portfolio of industry-leading products.

In 2020, Danaher (US) acquired the Biopharma business from General Electric Company’s (US) Life Sciences division. This subsidiary is called ‘Cytiva’ and will act as a standalone operating company within Danaher’s Life Sciences segment. This acquisition strengthened Danaher’s position in the oligo synthesizer and reagents market.

In 2020, Microsynth AG (Switzerland) launched Primer-Probe Sets for SARS-CoV-2.

In 2020, LGC Limited (UK) partnered with the Paraná Institute of Molecular Biology (IBMP) (Brazil) to supply reliable, high-quality custom GMP oligonucleotides and molecular products to develop a new molecular test for ZDC (zika, dengue, and chikungunya).

Key Questions Addressed in The Report:

1. Who are the top 10 players operating in the global oligonucleotide synthesis market?
2. What are the drivers, restraints, opportunities, and challenges in the oligonucleotide synthesis Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of oligonucleotide synthesis in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Regional Growth Analysis:

In 2020, North America accounted for the largest market share. The large share of this region can be attributed to the increasing R&D in life sciences, rising focus on improving the safety & quality of healthcare, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of many global players in this region is another key factor contributing to the large share of this market segment

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350

Key Players in Oligonucleotide Synthesis Market:

The oligonucleotide synthesis market is dominated by a few globally established players such as Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US). The prominent players in the oligonucleotide therapeutics market are Biogen Inc. (US) and Sarepta Therapeutics, Inc. (US).